Search for: "Monsanto Co." Results 361 - 380 of 505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2010, 6:39 am by Anna Christensen
  Looking forward, the New York Times reports on next week’s upcoming argument in Monsanto Co. v. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
25 Jan 2013, 5:05 am by Rachel Sachs
Monsanto Co., in which the Court will consider the application of the doctrine of patent exhaustion to self-replicating technologies. [read post]
22 Jan 2008, 7:24 pm
As a plaintiff in patent infringement suits, the university settled a claim against Genentech Inc. for $200 million, secured a payment of $185 million from Monsanto Co., and won a $30 million settlement from Microsoft Corp. [read post]
Monsanto Co., 467 U.S. 986 (1984), any disclosure of material to any recipient not bound to maintain secrecy destroys trade secret protection, and it was on the government to prove no disclosures ever occurred. [read post]
10 Feb 2014, 10:03 pm by Dan Flynn
It was been followed by a $160-million Clif Bar & Co. plant, also in Twin Falls; a $100-million expansion of a potato-processing plant at Burley, and the $30-million investment of a Portuguese fruit processor, the Frulact Group, in a plant near Rupert. [read post]
5 Apr 2015, 7:50 pm by Schachtman
Monsanto Co., 684 F.2d 1226, 1242 (7th Cir. 1982) (failure to consider factors identified by opposing side’s expert did not make testimony inadmissible). [2] In re Zoloft, 26 F. [read post]
24 Jan 2017, 11:41 am by Dennis Crouch
Monsanto Co., 133 S.Ct. 1761 (2013) and is also central to the case now pending before the Supreme Court, Impression Products, Inc. v. [read post]
10 Sep 2013, 4:00 am by Alan Macek
In a decision released in July, Merck & Co., Inc. v. [read post]
23 Mar 2007, 11:35 am
On the other hand, the Organisation for Economic Co-operation and Development (OECD, 2003) estimates that the USPTO grant rate for U.S. priority applications with at least one subsequent EPO application was consistently higher than the EPO grant rate for U.S. priority applications throughout the 1980s and early 1990sâ€â [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
23 Jul 2014, 10:01 pm by Lydia Zuraw
Glyphosate is the active ingredient in Roundup, the top-selling weed killer developed by Monsanto. [read post]
16 Aug 2011, 11:35 pm by Marie Louise
  General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges ‘bio-piracy’ by… [read post]
23 Jun 2010, 1:50 pm by Sheila McCorkle - Guest
The Court handed traditional alfalfa farmers a defeat in Monsanto Co. v. [read post]
15 Apr 2009, 4:44 am
Monsanto Co., 813 So.2d 827, 830-31 (Ala. 2001).AlaskaAs far as we can tell, no Alaska court has ever ruled on medical monitoring as a separate cause of action.ArizonaIt's only an intermediate appellate court, and it's pretty old, but based on Burns v. [read post]
12 May 2015, 3:26 pm by James Galvin
The following is a list of some of the UBS Reverse Convertible Notes offered: CUSIP Issuer Product Name 90261J426 UBS Yield Optimization Notes with Contingent Protection linked to Starbucks Corp. 90261J434 UBS Yield Optimization Notes with Contingent Protection linked to Intel Corp. 90261J459 UBS Yield Optimization Notes with Contingent Protection linked to Apple, Inc. 90261J319 UBS Yield Optimization Notes with Contingent Protection linked linked to Occidental Petroleum Corp. 90261J343 UBS… [read post]
3 Aug 2009, 11:36 am by Christopher Spizzirri
In applying this test, the Court cited the Delaware Superior Court’s decisions in Monsanto Co. v. [read post]